Literature DB >> 12525267

Antidepressants for chronic neuropathic pain.

Lori Reisner1.   

Abstract

Tricyclic antidepressants have been used to manage pain for several decades, and are superior treatments for some patients suffering from neuropathic pain. Unfortunately, older antidepressants have dose-limiting side effects that can lead to drug intolerance. The most common are anticholinergic side effects, although some patients experience sexual dysfunction. Cognitive impairment, sedation, and orthostatic hypotension also are relatively common. Taking an overdose of tricyclic antidepressants can be lethal in overdose. Several weeks of therapy may be required before antinociception occurs, but tricyclic antidepressants in optimal doses appear to be the most effective treatment for neuropathic pain; this is supported by systematic reviews comparing them with other agents. Newer medications such as atypical antidepressants and anticonvulsants may be overtaking older antidepressants, but they should not be overlooked as important options for the management of pain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525267     DOI: 10.1007/s11916-003-0006-4

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  61 in total

1.  Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions.

Authors:  M J Esser; T Chase; G V Allen; J Sawynok
Journal:  Eur J Pharmacol       Date:  2001-11-02       Impact factor: 4.432

2.  Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans.

Authors:  T P Enggaard; N A Klitgaard; L F Gram; L Arendt-Nielsen; S H Sindrup
Journal:  Clin Pharmacol Ther       Date:  2001-04       Impact factor: 6.875

Review 3.  Serotonin-containing neurons: their possible role in pain and analgesia.

Authors:  R B Messing; L D Lytle
Journal:  Pain       Date:  1977-10       Impact factor: 6.961

4.  A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy.

Authors:  R Biesbroeck; V Bril; P Hollander; U Kabadi; S Schwartz; S P Singh; W K Ward; J E Bernstein
Journal:  Adv Ther       Date:  1995 Mar-Apr       Impact factor: 3.845

5.  Percutaneous absorption of tricyclic antidepressants: amitriptyline, nortriptyline, imipramine, and desipramine.

Authors:  D N Bailey
Journal:  J Anal Toxicol       Date:  1990 Jul-Aug       Impact factor: 3.367

Review 6.  Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

Authors:  Søren H Sindrup; Troels S Jensen
Journal:  Pain       Date:  1999-12       Impact factor: 6.961

7.  Cholinergic mechanism in imipramine and morphine antinoception.

Authors:  V K Bhargava; L Saha
Journal:  Boll Chim Farm       Date:  2001 May-Jun

8.  Amitriptyline prevents N-methyl-D-aspartate (NMDA)-induced toxicity, does not prevent NMDA-induced elevations of extracellular glutamate, but augments kainate-induced elevations of glutamate.

Authors:  P P McCaslin; X Z Yu; I K Ho; T G Smith
Journal:  J Neurochem       Date:  1992-08       Impact factor: 5.372

9.  Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-D-aspartate-induced intracellular Ca2+ levels in neuronal culture.

Authors:  Z Cai; P P McCaslin
Journal:  Eur J Pharmacol       Date:  1992-08-14       Impact factor: 4.432

Review 10.  Antidepressants in chronic pain syndromes.

Authors:  K R Krishnan; R D France
Journal:  Am Fam Physician       Date:  1989-04       Impact factor: 3.292

View more
  4 in total

Review 1.  Recent advances in the pharmacological management of pain.

Authors:  Josée Guindon; Jean-Sébastien Walczak; Pierre Beaulieu
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Pain, pain, go away: antidepressants and pain management.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2008-12

3.  HDAC6-selective inhibitors decrease nerve-injury and inflammation-associated mechanical hypersensitivity in mice.

Authors:  Farhana Sakloth; Lefteris Manouras; Kleopatra Avrampou; Vasiliki Mitsi; Randal A Serafini; Kerri D Pryce; Valeria Cogliani; Olivier Berton; Matthew Jarpe; Venetia Zachariou
Journal:  Psychopharmacology (Berl)       Date:  2020-05-09       Impact factor: 4.415

Review 4.  Conotoxins targeting neuronal voltage-gated sodium channel subtypes: potential analgesics?

Authors:  Oliver Knapp; Jeffrey R McArthur; David J Adams
Journal:  Toxins (Basel)       Date:  2012-11-08       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.